Variables | All patients (n = 523) | Patients with active MM (n = 347) | Patients without active MM (n = 176) | P-value |
---|---|---|---|---|
Median eGFR (IQR) | 85 (62–91) | 84(60–91) | 86 (65–91) | 0,314 |
Creatinine (mg/dl) (IQR) | 0,83 (0,67-1,1) | 0,84 (0,66-1,12) | 0,82 (0,68-1,07) | 0,854 |
MM Type | ||||
IgG (%) | 198 (57) | |||
IgA (%) | 88 (25,4) | |||
IgM (%) | 6 (1,7) | |||
IgD (%) | 4 (1,1) | |||
IgG + IgA (%) | 6 (1,7) | |||
Bence-Jones (%) | 44 (12,7) | |||
Non-secretory (%) | 1 (0,3) | |||
FLC type | ||||
Κ sFLC (%) | 227 (65,4) | |||
λ sFLC (%) | 114 (32,8) | |||
Κ + λ sFLC (%) | 5 (1,4) | |||
Non-secretory (%) | 1 (0,3) | |||
FLC level (mg/L) | ||||
Median k sFLC (IQR) | 21,1 (11,5-65,4) | 26,4 (10,9–147) | 17,35 (12,27-32,12) | < 0.001 |
Median λ sFLC (IQR) | 13,8 (7,5-28,6) | 11,2 (6,2-30,4) | 16,4 (11,5-26,47) | 0,001 |
Median sFLC ratio (IQR) | 1,34 (0,77-6,24) | 2,5 (0,49-17,65) | 1,11 (0,89-1,39) | < 0.001 |